Medicare Monday: PhRMA ’s comments on new direction for CMMI

Today, PhRMA submitted its comments in response to the Centers for Medicare& Medicaid Services (CMS) request for information on the future of the Center for Medicare and Medicaid Innovation (CMMI). While well intentioned, CMMI ’s current flexibility to make far-reaching changes has raised a number of concerns about large-scale mandatory demonstrations developed without stakeholder input, such as theproposed Part B drug payment model that was recently withdrawn. We welcome the Administration ’s call for feedback and look forward to working with them on the evolution of CMMI. Here are some of our suggestions for the new direction of CMMI:
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare CMMI Source Type: news